Metagenomi (NasdaqGS:MGX) 2025 Conference November 20, 2025 04:30 AM ET Company ParticipantsJian Irish - CEOModeratorMorning and welcome to the Jefferies 2025 Global Healthcare Conference. It is my pleasure to now introduce Gian Irish, CEO, and Pam Wapnick, CFO of Metagenomi. Just as a reminder, this will be a 25-minute presentation. Thank you.Jian IrishOkay, good morning, everybody. Thank you very much for—very glad to be here. Gian Irish, I'm the CEO of Metagenomi. Pleasure to be here. Before we begin, pl ...

EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A, President and Chief Executive Officer of Metagenomi, will be presenting at the Jefferies Global Healthcare Conference in London on Thursday, November 20, 2025, at 9:30 a.m. GMT. A live webcast will be available in the investor sectio ...